Concepedia

Naomi Shimazaki

NS

Statistics

Publications

2

Citations

88

H-Index

2

Active since

2008

Affiliations

Daiichi-Sankyo (Japan)(Current)

Daiichi Sankyo (Germany)

Naomi Shimazaki is an author at Daiichi-Sankyo (Japan) specializing in tumor biology, cell biology, and cancer research.

Top concepts

MedicineCell BiologyPharmacologyTumor BiologyCancer ResearchTumor MicroenvironmentApoptosisPathologyCell DeathCancer Therapy

Publications per year

2008–2022

2

Publications

2

Anti-tumour activity of CS-7017, a selective peroxisome proliferator-activated receptor gamma agonist of thiazolidinedione class, in human tumour xenografts and a syngeneic tumour implant model

Naomi Shimazaki, Noriko Togashi, Masaharu Hanai et al. · European Journal of Cancer · 2008 · 61 citations

Human Tumour Xenografts, Thiazolidinedione Class, Medicine +10

Potent and Selective PTDSS1 Inhibitors Induce Collateral Lethality in Cancers with PTDSS2 Deletion

Yohei Yoshihama, Hidenori Namiki, Taiga Kato et al. · Cancer Research · 2022 · 27 citations

Apoptosis, Cell Death, Pathology +18

1–2 of 2